WILL SGLT2 INHIBITORS PROVE TO BE A 'MULTIPLE' GAMECHANGER? (2019)
Attributed to:
Integrative genomic, epigenetic and functional studies in diabetic kidney disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
PubMed Identifier: 30675070
Publication URI: http://europepmc.org/abstract/MED/30675070
Type: Journal Article/Review
Volume: 88
Parent Publication: The Ulster medical journal
Issue: 1
ISSN: 0041-6193